Ellis IO - Search Results

1

CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome.

Elsheikh S, Green AR, Aleskandarany MA, Grainge M, Paish CE, Lambros MB, Reis-Filho JS, Ellis IO. Elsheikh S, et al. Among authors: ellis io. Breast Cancer Res Treat. 2008 May;109(2):325-35. doi: 10.1007/s10549-007-9659-8. Epub 2007 Jul 26. Breast Cancer Res Treat. 2008. PMID: 17653856

2

The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.

Pinder SE, Ellis IO. Pinder SE, et al. Among authors: ellis io. Breast Cancer Res. 2003;5(5):254-7. doi: 10.1186/bcr623. Epub 2003 Jul 29. Breast Cancer Res. 2003. PMID: 12927035 Free PMC article. Review.

3

Loss of CD55 is associated with aggressive breast tumors.

Madjd Z, Durrant LG, Bradley R, Spendlove I, Ellis IO, Pinder SE. Madjd Z, et al. Among authors: ellis io. Clin Cancer Res. 2004 Apr 15;10(8):2797-803. doi: 10.1158/1078-0432.ccr-1073-03. Clin Cancer Res. 2004. PMID: 15102687

4

Expression of luminal and basal cytokeratins in human breast carcinoma.

Abd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JF, Nicholson RI, Ellis IO. Abd El-Rehim DM, et al. Among authors: ellis io. J Pathol. 2004 Jun;203(2):661-71. doi: 10.1002/path.1559. J Pathol. 2004. PMID: 15141381

5

Expression of E2F-4 in invasive breast carcinomas is associated with poor prognosis.

Rakha EA, Pinder SE, Paish EC, Robertson JF, Ellis IO. Rakha EA, et al. Among authors: ellis io. J Pathol. 2004 Jul;203(3):754-61. doi: 10.1002/path.1573. J Pathol. 2004. PMID: 15221934

6

Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis.

Putti TC, El-Rehim DM, Rakha EA, Paish CE, Lee AH, Pinder SE, Ellis IO. Putti TC, et al. Among authors: ellis io. Mod Pathol. 2005 Jan;18(1):26-35. doi: 10.1038/modpathol.3800255. Mod Pathol. 2005. PMID: 15332092 Free article.

7

High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry.

Rakha EA, Armour JA, Pinder SE, Paish CE, Ellis IO. Rakha EA, et al. Among authors: ellis io. Int J Cancer. 2005 May 1;114(5):720-9. doi: 10.1002/ijc.20738. Int J Cancer. 2005. PMID: 15609312

8

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.

Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JF, Macmillan D, Blamey RW, Ellis IO. Abd El-Rehim DM, et al. Among authors: ellis io. Int J Cancer. 2005 Sep 1;116(3):340-50. doi: 10.1002/ijc.21004. Int J Cancer. 2005. PMID: 15818618

9

Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis.

Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane JP, Hanby A, Pinder SE, Lee AH, Humphreys S, Ellis IO, Lakhani SR. Simpson PT, et al. Among authors: ellis io. Am J Surg Pathol. 2005 Jun;29(6):734-46. doi: 10.1097/01.pas.0000157295.93914.3b. Am J Surg Pathol. 2005. PMID: 15897740

10

A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes.

Garcia MJ, Pole JC, Chin SF, Teschendorff A, Naderi A, Ozdag H, Vias M, Kranjac T, Subkhankulova T, Paish C, Ellis I, Brenton JD, Edwards PA, Caldas C. Garcia MJ, et al. Oncogene. 2005 Aug 4;24(33):5235-45. doi: 10.1038/sj.onc.1208741. Oncogene. 2005. PMID: 15897872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

771 results

Search Page

Filters